Heidary Mohsen, Dashtbin Shirin, Ghanavati Roya, Mahdizade Ari Marzie, Bostanghadiri Narjess, Darbandi Atieh, Navidifar Tahereh, Talebi Malihe
Cellular and Molecular Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran.
Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Front Vet Sci. 2022 Jul 18;9:925773. doi: 10.3389/fvets.2022.925773. eCollection 2022.
Brucellosis is a bacterial zoonosis caused by spp. which can lead to heavy economic losses and severe human diseases. Thus, controlling brucellosis is very important. Due to humans easily gaining brucellosis from animals, animal brucellosis control programs can help the eradication of human brucellosis. There are two popular vaccines against animal brucellosis. Live attenuated strain 19 (S19 vaccine) is the first effective and most extensively used vaccine for the prevention of brucellosis in cattle. Live attenuated strain Rev.1 (Rev.1 vaccine) is the most effective vaccine against caprine and ovine brucellosis. Although these two vaccines provide good immunity for animals against brucellosis, the expense of persistent serological responses is one of the main problems of both vaccines. The advantages and limitations of vaccines, especially new vaccine candidates, have been less studied. In addition, there is an urgent need for new strategies to control and eradicate this disease. Therefore, this narrative review aims to present an updated overview of the available different types of brucellosis vaccines.
布鲁氏菌病是一种由布鲁氏菌属细菌引起的人畜共患病,可导致重大经济损失和严重的人类疾病。因此,控制布鲁氏菌病非常重要。由于人类很容易从动物身上感染布鲁氏菌病,动物布鲁氏菌病防控计划有助于根除人类布鲁氏菌病。有两种常用的抗动物布鲁氏菌病疫苗。减毒活疫苗19株(S19疫苗)是第一种用于预防牛布鲁氏菌病的有效且应用最广泛的疫苗。减毒活疫苗Rev.1株(Rev.1疫苗)是预防山羊和绵羊布鲁氏菌病最有效的疫苗。尽管这两种疫苗能为动物提供良好的抗布鲁氏菌病免疫力,但持续性血清学反应带来的问题是这两种疫苗的主要问题之一。布鲁氏菌病疫苗,尤其是新型候选疫苗的优缺点研究较少。此外,迫切需要新的策略来控制和根除这种疾病。因此,本叙述性综述旨在对现有的不同类型布鲁氏菌病疫苗进行最新概述。